Teva UK announces new chief executive officer

Teva UK has announced that Dipankar Bhattacharjee has been appointed as the firm’s new chief executive officer.

He replaces John Beighton, who has taken on a new role within the organisation, that of vice-president of global business optimisation in the firm’s new Teva Generic Systems group.

Mr Bhattacharjee is described as a “highly experienced international business leader” and as having an “impressive” track record in the sales, management and marketing sectors for a range of medical device, over-the-counter and pharmaceutical companies.

Commenting on his appointment, Mr Bhattacharjee said that he is looking forward to joining an enterprise that is a leader in its field.

He added: “I’m a great admirer of Teva’s momentum for growth, strong results orientation and above all the company’s long-term commitment to maintain its position as the UK market leader in generic medicines.”

Earlier this month, Teva announced that it has opened up its student bursary scheme for the second consecutive year.